diagnosis, in the outcome of heart failure in the form of in hospital mortality is studied. . Many studies Method

Size: px

Start display at page:

Download "diagnosis, in the outcome of heart failure in the form of in hospital mortality is studied. . Many studies Method"

Quentin Wheeler
7 years ago
Views:

1 2013; 16 (2) Original article Poudel C M 1 Correspondence to : 1 Abstract Background: diagnosis, in the outcome of heart failure in the form of in hospital mortality is studied. Methods: Results: mortality. Conclusion: Severe anaemia at the time of diagnosis of heart failure is an independent predictor of in hospital mortality. Introduction. Many studies heart failure is an independent factor for mortality during over time. Of note, anemia is not only prevalent in the studies in different patient populations found an association., some studies report the absence of an adverse effect of anemia on mortality in. Elucidating the contribution of anemia to mortality may lead since several treatment options for anemia exist including may lead to more effective therapeutic strategies from a In this study, the effect of severe anaemia in the outcome Method Patient population One hundred eighty four heart failure patients admitted The initial screening consisted of a clinical history, a physical examination, and baseline investigations at

2 2013; 16 (2) 7-11 Poudel C M... during the hospital stay. mmol per liter, recent use of class I or III antiarrhythmic drugs, a calculated creatinine clearance rate of less myocarditis, planned cardiac surgery or angioplasty, severe. enrolment. The study received ethical approval from Statistical analysis th discrete variables as percentages. Baseline characteristics for discrete variables and analysis of continuous variables. Results Prevalence of anaemia Ethics No anaemia (N= 69) Mild anaemia (N= 38) Table 1 Baseline characteristics of heart failure patients. Moderate anaemia (N= 58) Severe anaemia (N= 19) P value Creat Clearance Statin

3 2013; 16 (2) 7-11 Poudel C M... Mortality analysis When evaluated in a bivariate model, the odds ratio of death respectively. creatinine clearance, presence of arrhythmia, ejection Table 2 Multivariate analysis of mortality with anaemia Category of anaemia P value Odds ratio No anaemia reference Mild anaemia Moderate anaemia Severe anaemia Discussion reports of other studies. It could be due to poor nutritional morbidity. Both the short term and long term studies including a recent anaemia. This study is a prospective study of admitted patients on bivariate analysis. Furthermore on assessing the importance of severity of anaemia on multivariate analysis, In this study patients had no signs of cancer at the time of inclusion leading to the argument that anaemia in the disease. This is illustrated in our study by the fact that the. In relation to these trials there has recently been Acknowledgements References 1. et al. role in a controlled trial and in clinical practice. J Card et al and mortality in heart failure patients a systematic

4 2013; 16 (2) 7-11 Poudel C M et al. Effects of darbepoetin alpha on right and left ventricular systolic heart failure secondary to ischemic or idiopathic et al its relationship to clinical outcome in heart failure. et al its relationship to clinical outcome in heart failure. McMurray JJ. The prevalence, nature, and importance 11. symptoms, greater impairment in functional capacity 13. failure inpatients admitted for acute decompensation.

5 2013; 16 (2) 7-11 Poudel C M... concentrations for the diagnosis of anaemia and assessment of severity. indicators/haemoglobin. pdf. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal 31. et al. Effect of darbepoetin alfa on exercise tolerance in anemic et al 11

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains